| Assay Method Information | |
| | Homogeneous time resolved fluorescence (HTRF) |
| Description: | The identified compounds were tested for their capacity to inhibit the PD-1/PD-L1 interaction using in vitro functional assays. Homogeneous time resolved fluorescence (HTRF) was used to evaluate those 94 hits identified in silico. The BMS202 inhibitor, known as a small-molecule inhibitor of PD-1/PD-L1 interaction, was used as a reference. Compounds were tested at 100 μM and the determination of the inhibition levels was based on the HTRF signal reduction. Hits were defined as compounds that inhibited at least 50% of the PD-1/PD-L1 interaction. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |